News
Continuing Our Investment in Technology, Vaniam Group™ Announces the Hire of Binish Khan as SVP of Digital Engagement
As Senior Vice President, Ms. Khan will champion innovative digital solutions and new offerings for Vaniam Group clients
Vaniam Group™ Accelerates Innovation With Appointment of Industry Leader Steve Tulk as Chief Technology Officer
Mr Tulk will spearhead innovative digital solutions, advanced analytics, and new offerings for Vaniam Group’s clients.
Vaniam Group™ Welcomes Christa Gott as Senior Vice President of Business Strategy
Ms Gott’s extensive background in hematology and solid tumors, as well as her biopharma experience, will drive strategic initiatives, enhance client solutions, and foster long-term client relationships.
Bio Ascend, a Vaniam Group Company, Holds Second Class of Next Wave Forum for Young Investigators in Thoracic Oncology™
Eighteen early-career clinical investigators to receive year-long mentorship through professional development program led by international thought leaders
Vaniam Group™ and Women Leaders in Oncology® Announce 2024 Young Investigator Awards, Advancing Diversity and Equity in Cancer Research
Leou Ismael Banla, MD, PhD, receives annual Conquer Cancer-Vaniam Group LLC Young Investigator Award, dedicated to Black, African, or African American cancer researchers and Erica Pimenta, MD, PhD, receives annual Conquer Cancer-Women Leaders in Oncology “Women Who Conquer Cancer” Young Investigator Award
Vaniam Group™ Presents Data on Improving Clinical Trial Performance at the 2024 ASCO Annual Meeting
Vaniam Group CSS (Clinical Strategy and Solutions) poster focuses on “Improving Clinical Trial Performance Using Adult-Learning Methods”
Vaniam Group™ Hires Carol Scholz as Executive Vice President of Client Solutions
Ms. Scholz brings 25 years of leadership experience driving the success of oncology brands across several top pharmaceutical companies
Bio Ascend, a Vaniam Group Company, Reconvenes Inaugural Class of the “Academy of Next Wave of Investigators™” in CLL and NHL
Early-career clinical investigators continue year-long mentorship and professional development program led by international thought leaders
